BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16757129)

  • 1. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Hart AA; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):11-9. PubMed ID: 16757129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
    Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study.
    Fellin G; Fiorino C; Rancati T; Vavassori V; Baccolini M; Bianchi C; Cagna E; Gabriele P; Mauro F; Menegotti L; Monti AF; Stasi M; Valdagni R
    Radiother Oncol; 2009 Nov; 93(2):197-202. PubMed ID: 19828205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
    Tucker SL; Cheung R; Dong L; Liu HH; Thames HD; Huang EH; Kuban D; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):353-65. PubMed ID: 15145148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer.
    Rancati T; Fiorino C; Fellin G; Vavassori V; Cagna E; Casanova Borca V; Girelli G; Menegotti L; Monti AF; Tortoreto F; Delle Canne S; Valdagni R
    Radiother Oncol; 2011 Jul; 100(1):124-30. PubMed ID: 21741721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy.
    Heemsbergen WD; Hoogeman MS; Hart GA; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1011-8. PubMed ID: 15752880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome.
    Valdagni R; Kattan MW; Rancati T; Yu C; Vavassori V; Fellin G; Cagna E; Gabriele P; Mauro FA; Baccolini M; Bianchi C; Menegotti L; Monti AF; Stasi M; Giganti MO; Fiorino C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1957-66. PubMed ID: 21640511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
    Strigari L; Arcangeli G; Arcangeli S; Benassi M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage.
    Heemsbergen WD; Peeters ST; Koper PC; Hoogeman MS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):3-10. PubMed ID: 16814954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients.
    Schaake W; van der Schaaf A; van Dijk LV; Bongaerts AH; van den Bergh AC; Langendijk JA
    Radiother Oncol; 2016 Jun; 119(3):381-7. PubMed ID: 27157889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of late rectal toxicity after radiation therapy for prostate cancer.
    Odrazka K; Dolezel M; Vanasek J; Vaculikova M; Zouhar M; Sefrova J; Paluska P; Vosmik M; Kohlova T; Kolarova I; Macingova Z; Navratil P; Brodak M; Prosvic P
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):138-43. PubMed ID: 20038960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of intestinal symptoms and fecal continence in patients with conformal radiotherapy for prostate cancer.
    Geinitz H; Thamm R; Keller M; Astner ST; Heinrich C; Scholz C; Pehl C; Kerndl S; Prause N; Busch R; Molls M; Zimmermann FB
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1373-80. PubMed ID: 21030158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.